LiDORx (Lidocaine HCL USP 3%) Mobile Program: Terms, Conditions, and Eligibility Requirements:
By participating in the LiDORx (Lidocaine HCL USP 3%) Mobile Program (“Program”) sponsored by Gensco Pharma, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:
- The Program is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state health care programs, including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma De Salud”).
- Absent a change in Massachusetts law, effective July 1, 2015, the discount will no longer be valid for residents of Massachusetts.
- The Program is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs that reimburse you for the entire cost of your prescription drugs.
- Patients must be 18 or older. Cash paying patients and privately insured patients are eligible for savings. Patients will pay a minimum of $20 per fill for all eligible prescription sizes of LiDORx.
- For LiDORx size 30 mL, cash paying patients pay a minimum copay of $20 and are eligible for a maximum savings of up to $62.27 per fill. Privately insured patients pay a minimum copay of $20 and are eligible for maximum savings of up $25.45. For LiDORx size 10 mL, cash paying and privately insured patients pay a minimum copay of $20 with a maximum savings of up to $10 per fill.
- This discount is not health insurance. This Program is good only in the United States and Puerto Rico. You must deduct the value received under this Mobile Program from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf.
- The Program cannot be combined with any other rebate or coupon, free trial, or similar offer for the specified prescription.
- It is illegal to sell, purchase, trade, or counterfeit, or offer to sell, purchase, trade, or counterfeit the discount card. Void if reproduced. Void where prohibited by law, taxed, or restricted.
- The discount will be accepted only at participating pharmacies. Participating mail order pharmacies must receive the program details, including the pharmacy processing line (888-445-5573) along with your prescription to process the offer.
- The discount will be accepted only at participating pharmacies. Participating mail order pharmacies must receive the program details, including the pharmacy processing line (888-445-5573) along with your prescription to process the offer.
- Under the Program you may receive information about your prescription via text message. Standard message and data rates may apply. You may receive an average of 8 messages per month during the course of this program. Text messages received within the Program are automated and responses are not read by any person.
- If you wish to opt out at any time during the program, text STOP to opt out. Text HELP for help.
- Gensco Pharma reserves the right to rescind, revoke, or amend the discount without notice. For questions about this discount program or how to opt out, please call 855-7GENSCO (855-746-6726). No membership fees required.
- The discount card is the property of Gensco Pharma and must be turned in on request.
© 2015 Gensco Pharma. All rights reserved. For full LiDORx Prescribing information click here
OUR SCIENCE
Gensco® Pharma’s abilities provide boundless possibilities for improving health utilizing our unique preparations, innovative dosing methods, and proprietary drug delivery technologies.
Transdermal Technology Gensco® Pharma has developed and patented a unique transdermal drug delivery system... read more
MDose® Gensco® Pharma’s patented topical metered dose applicator dispenses an exact and consistent dose of medication with every pump... read more
PRODUCTS
LidoDose® The Single Dose™ Topical Anesthetic & Antiseptic for Preprocedural Use... read more
ColciGel® Prepare for the flare with the first transdermal treatment for gout flares... read more
Astero® The first FDA-approved prescription combination drug-device hydrogel containing Lidocaine 4% HCl for associated pain, wound healing and vasculitis.... read more
LiDORx® Delivers fast controlled pain relief at the site... read more
SpeedGel Rx® Non-NSAID alternative for pain, inflammation and bruising. Targeting the source of pain... faster... read more
PROFESSIONAL EVENTS
There are no upcoming events at this time. Go to full list of events here.
GENSCO® TRENDING
- Gensco® Pharma Announces RizaFilm® Commercialization Update in the United States September 26, 2023 Featured, Industry, Press Release, Product Update - Gensco® Pharma, a specialty pharmaceutical company, in partnership with IntelGenx is announcing the anticipated launch… more...
- Skin Tears Treatment Market to Observe Strong Development by 2018-2026 April 15, 2019 Articles, Featured, Industry - [To download a printable version of this article, click here] MARKET RESEARCH April 12, 2019… more...
- Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAFILM® (U.S. market name for RIZAPORT® — Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in… more...
- AAP Issues Flu Vaccine Recommendations for 2018-2019 September 6, 2018 Articles, Industry - All children should receive the flu shot as soon as it is available: AAP [To… more...